Key Highlights
- Phreesia’s contract with CMS Innovation Center extended through 2029.
- PAM performance measure used in CMS’s alternative payment models.
- Supports Kidney Care Choices Model improving care for 200,000 CKD patients.
- PAM scores increased by 8.8 points; 12.8-point increase among transplant patients.
- PAM adoption helps reduce disparities among disadvantaged patient populations.
Source: Business Wire
Notable Quotes
- “Care teams drove significant increases in PAM scores…meaning tens of thousands of kidney care patients are taking a more active role in their care.” — Hilary Hatch, PhD, Chief Clinical Officer at Phreesia
- “Patient activation is powerful, I’ve used it in my own practice…we’ll see continued improvements in outcomes—as well as cost reductions—in future years of the KCC Model.” — Alan Glaseroff, MD, Co-Founder at Stanford Coordinated Care
SoHC's Take
Phreesia’s renewal with CMS Innovation Center solidifies its leadership in patient activation, particularly through the Kidney Care Choices Model. The notable increase in PAM scores and improved clinical outcomes reflect the impact of incentivizing clinicians to engage patients actively. As CMMI looks to expand PAM’s use across more care settings, Phreesia’s continued support is crucial in addressing healthcare disparities and improving care for chronic disease patients. The results from year one of the KCC Model set a promising precedent for cost reduction and enhanced patient care.
